ClinicalTrials.Veeva

Menu

Comparing of Different Biomarkers From Vena Rectalis Superior and Vena Cubiti in Patients Undergoing Low Anterior Resection for Rectum Cancer

O

Odense University Hospital

Status

Unknown

Conditions

Rectal Cancer

Treatments

Other: blood sampels from vena rectalis superior and vena cubiti

Study type

Observational

Funder types

Other

Identifiers

NCT01706809
S-20100006

Details and patient eligibility

About

The primary aim of the present study is to investigate different biomarkers like VEGF, EVGF and others ability to predict time to recidive and progressions free survival.

Full description

Patients undergoing LAR for rectum cancer is subjected. Preoperative blood samples from vena rectalis superior and vena cubiti is collected, as well as biopsies from tumor. Preoperative and after 3 month peripheral blood samples is collected.

A total of 50 patients will be included in this study.

The study is approved by the local scientific ethical committee No. S-20100006

Enrollment

30 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Histological verified cancer
  • The cancer must be located in rectum maximum of 15 cm.
  • Age above 18

Exclusion criteria

  • Disseminated cancer
  • Perioperative radio-chemotherapy
  • Laparoscopy surgery

Trial design

30 participants in 1 patient group

Biomarkeres
Treatment:
Other: blood sampels from vena rectalis superior and vena cubiti

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems